Swaminathan S, Umadevi P, Shantha S, Radhakrishnan A, Datta M
Tuberculosis Research Centre, ICMR, Chetput, Chennai.
Indian J Pediatr. 1999 Nov-Dec;66(6):837-42. doi: 10.1007/BF02723848.
The diagnosis of childhood tuberculosis is based on circumstantial evidence in the absence of a gold standard in the majority of cases. Sero-diagnosis offers scope for an early diagnosis in a variety of clinical conditions and is simple to perform. A number of mycobacterial antigens have been used for antibody detection assays and several are available as kits in the market. This study was done to evaluate the value of antibody detection kits (ELISA) against the A60 antigen and 38 kDa antigen of Mycobacterium tuberculosis in the diagnosis of childhood tuberculosis at the outpatient department of the Institute of Social Paediatrics, Government Stanley Hospital in collaboration with Tuberculosis Research Centre, Chennai. Thirty five children with pulmonary tuberculosis, 7 with TB lymphadenitis and 22 healthy controls were studied. In addition to routine investigations including gastric lavage for AFB culture, serum antibodies against the A60 and 38 kDa antigens were assayed using commercially available ELISA kits. With A60, IgM serum levels were positive in 74% of pulmonary TB cases, 57% of TB lymphadenitis cases and 50% of controls. A60 IgG was positive in 17% of pulmonary TB, 86% of TB lymphadenitis and 14% of controls. The 38 kDa IgG antibody was positive in 37% of pulmonary and 86% of TB lymphadenitis cases and 27% of controls. Among 10 culture confirmed cases, A60 IgM was positive in 8, A60 IgG in 3 and 38 kDa IgG in 5 patients. The sensitivity of the tests ranged between 29% and 71% and specificity between 50% and 86%. Although the numbers are small, the results suggest that serodiagnosis using the currently available antigens of M. tuberculosis is unlikely to be a confirmatory test for tuberculosis in children.
在大多数情况下,儿童结核病的诊断是基于间接证据,因为缺乏金标准。血清学诊断为多种临床病症的早期诊断提供了可能,且操作简便。多种分枝杆菌抗原已用于抗体检测试验,市场上有几种作为试剂盒可供使用。本研究由政府斯坦利医院社会儿科学研究所门诊部与金奈结核病研究中心合作开展,旨在评估针对结核分枝杆菌A60抗原和38 kDa抗原的抗体检测试剂盒(酶联免疫吸附测定法)在儿童结核病诊断中的价值。研究对象包括35例肺结核患儿、7例结核性淋巴结炎患儿和22名健康对照。除了包括通过洗胃进行抗酸杆菌培养的常规检查外,还使用市售酶联免疫吸附测定试剂盒检测了针对A60和38 kDa抗原的血清抗体。对于A60抗原,肺结核病例中74%的IgM血清水平呈阳性,结核性淋巴结炎病例中为57%,对照中为50%。肺结核病例中17%的A60 IgG呈阳性,结核性淋巴结炎病例中为86%,对照中为14%。38 kDa IgG抗体在肺结核病例中37%呈阳性,结核性淋巴结炎病例中为86%,对照中为27%。在10例培养确诊病例中,8例A60 IgM呈阳性,3例A60 IgG呈阳性,5例38 kDa IgG呈阳性。这些检测的敏感性在29%至71%之间,特异性在50%至86%之间。尽管样本数量较少,但结果表明,使用目前可用的结核分枝杆菌抗原进行血清学诊断不太可能成为儿童结核病的确证性检测方法。